STAAStaar Surgical Co.
$29.10
$0.20
(0.69%)
Pre-Market
Reported EarningsMay 13
Mkt Cap$1.46B
Vol613,345.00
Fundamentals
Mkt Cap
$1.46B
Volume
-
52W High
$35.87
52W Low
$15.59
PE Ratio
-67.30
Avg. Volume
1.13M
EPS (Annual)
-$1.62
Rev/Employee
$250,200.63
Earnings
May 13
STAAR Surgical Announces Participation in Upcoming Investor Conferences
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, today announced that management will participate in the following upcoming conferences: Stifel 2026 Virtual Ophthalmology Forum Date: Tuesday...
Business Wire
Compared to Estimates, Staar Surgical (STAA) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Staar Surgical (STAA) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks
Staar Surgical (STAA) Tops Q1 Earnings and Revenue Estimates
Staar Surgical (STAA) delivered earnings and revenue surprises of +192.31% and +1.88%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
STAAR Surgical Reports First Quarter 2026 Results; Issues Shareholder Letter
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, today reported results for the first...
Business Wire
McKesson (MCK) Surpasses Q4 Earnings Estimates
McKesson (MCK) delivered earnings and revenue surprises of +1.14% and -5.52%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Lifevantage (LFVN) Q3 Earnings and Revenues Miss Estimates
Lifevantage (LFVN) delivered earnings and revenue surprises of -25.00% and -8.58%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
STAAR Surgical to Host First Quarter 2026 Earnings Results Call and Webcast on May 13, 2026
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, today announced that it will release financial results in combination with a shareholder letter for the first quarter ended April 3, 2026, on...
Business Wire
McKesson (MCK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Staar Surgical (STAA) Earnings Expected to Grow: What to Know Ahead of Q1 Release
Staar Surgical (STAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
<
1
2
...
>
Advertisement|Remove ads.
Latest STAA News
ViewSTAAR Surgical Announces Participation in Upcoming Investor Conferences
Business Wire
STAA Stock On Track For Its Fourth Straight Session Of Gains – This Analyst Would Rather Be Early Than Late On Staar’s Growth Story
Stocktwits
Compared to Estimates, Staar Surgical (STAA) Q1 Earnings: A Look at Key Metrics
Zacks
Advertisement|Remove ads.